Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression
2017 · Nature Communications · 203 citations
https://doi.org/10.1038/s41467-017-01947-w
B
Bruce G. Haffty
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
931
Papers
30.5K
Citations
88
h-index
379
i10-index
Bruce G. Haffty is an academic researcher from Rutgers, The State University of New Jersey. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Advanced Radiotherapy Techniques. The author has an h-index of 88, co-authored 792 publications.
ORCID: 0000-0002-9597-6019Papers by this author
worksExpression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
1998 · PubMed · 150 citations
Cullin3–KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression
2016 · Genes & Development · 148 citations
https://doi.org/10.1101/gad.283283.116
Local recurrence versus new primary: Clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting
1993 · International Journal of Radiation Oncology*Biology*Physics · 107 citations
https://doi.org/10.1016/0360-3016(93)90382-6
Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression
2020 · Journal of Clinical Investigation · 92 citations
https://doi.org/10.1172/jci132876
Five‐year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation
2010 · Cancer · 84 citations
https://doi.org/10.1002/cncr.25383
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat